关于非那雄胺你想知道的,这一篇给你答案
Benign prostatic hyperplasia (BPH) is a chronic, progressive disease that mainly affects men over the age of 60. Finasteride is a type II 5α reductase inhibitor (5ARI) that treats BPH patients with moderate to severe lower urinary tract symptoms (LUTS) by delaying disease progression. Studies have shown that 5ARI treatment for more than 2 years can significantly reduce prostate volume (PV), transition zone volume (TZV) and peripheral zone volume. Today, this article will give you the answer to what you want to know.
Finasteride has a chemical structure similar to that of testosterone. It can competitively, selectively and specifically block the activity of type II 5a-proenzyme, inhibit the production of dihydrotestosterone, and thereby inhibit the conversion of testosterone into dihydrotestosterone. Some studies have reported that long-term application of finasteride can reduce the prostate volume by 20% to 30%, increase urinary flow rate, reduce the severity of clinical symptoms, and improve patients' urethral function. It can also reduce the risk of surgical treatment, enhance clinical efficacy, and reduce the incidence of acute urinary retention. Many studies have pointed out that finasteride has significant efficacy in the clinical treatment of BPH patients and can be used as a safe and effective therapeutic drug commonly used in clinical practice.
It is 5 mg (1 tablet) each time, once a day, and can be taken on an empty stomach or with food. Common side effects include impotence, itching, decreased libido, hives, decreased ejaculation, rash, breast tenderness or enlargement, swollen lips, allergic reactions, testicular pain, etc.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended hot articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)